Yoon, B
These mechanisms necessitate further investigation into the pathways of GLP-1RA involvement in the clinical course of DR to learn if they hold substantial value beyond a pre-clinical setting [91]
Huang, S., Wang, L., Huang, C., Su, W., & Xiao, Q
Healthcare providers who choose to prescribe off-label dosing should document their clinical rationale, discuss the experimental nature of the approach with patients, and implement appropriate monitoring protocols to assess both safety and efficacy
Food and Drug Administration (FDA) for the management of type 2 diabetes in combination with exercise and a low-calorie diet
When is FDA approval expected for this triple agonist